Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | Yttrium-90 microsphere therapy |
| Synonyms | |
| Therapy Description |
Yttrium-90 microsphere therapy is a radioembolization therapy consisting of the radioisotope Yttrium-90 (Y90) delivered via resin or glass microspheres, which potentially delivers localized radiation to tumors (PMID: 26020025, PMID: 25449754, PMID: 26943239). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| Yttrium-90 microsphere therapy | SIR-Spheres Yttrium 90|Y90 Microspheres | Yttrium-90 microsphere therapy is a radioembolization therapy consisting of the radioisotope Yttrium-90 (Y90) delivered via resin or glass microspheres, which potentially delivers localized radiation to tumors (PMID: 26020025, PMID: 25449754, PMID: 26943239). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT05620771 | Phase II | Yttrium-90 microsphere therapy Atezolizumab + Bevacizumab | Therasphere and Systemic Therapy for Patients With Hepatocellular Carcinoma That is High-risk | Suspended | USA | 0 |